Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TNM002 in Chinese Healthy Adults
Clinical trial NCT05842798 · COMPLETED
Trial details
- NCT number
- NCT05842798
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-15
- Primary completion
- 2022-02-24
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.